ARTV vs TPR · $37.3M cap vs P/E 46, rev $8.00B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
ARTV currently screens at market cap $37.3M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the ARTV and TPR stock pages for the full models.
Not investment advice.